The economic impact of acute variceal bleeding: cost-effectiveness implications for medical and surgical therapy.
The hospital costs and its respective components for 32 patients with acute variceal bleeding were determined. The average total cost for treating the 32 patients was $35,000. The cost for those patients who underwent elective surgery ($53,000) was approximately twofold that of the elective medical group. Nutritional and metabolic rehabilitation that prolonged hospitalization, reutilization of the intensive care unit, and perioperative blood requirements were the significant factors that increased the cost of treating the surgically treated patients. Derivation of the cost/benefit ratio, however, showed that the decreased rehospitalization rate of the surgically treated group and the apparent better "quality of life" almost offset the increased initial hospital costs for this group.
D000328:Adult; D000368:Aged; D001803:Blood Transfusion; D003362:Cost-Benefit Analysis; D004932:Esophageal and Gastric Varices / Q000191:economics* / Q000601:surgery / Q000628:therapy; D006471:Gastrointestinal Hemorrhage / Q000191:economics / Q000601:surgery / Q000628:therapy; D006801:Humans; D008875:Middle Aged; D011170:Portasystemic Shunt, Surgical; D014667:Vasopressins / Q000627:therapeutic use
D014667:Vasopressins